SEC Form 4 · accession 0001209191-18-048513
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg S Sutton
Officer — VP of Research and Development
Period of report
Aug 23, 2018
Accepted (ET)
Aug 27, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 23, 2018 | M | 10,544 | $19.42 | A | 19,853 | D | |
| Common Stock | Aug 23, 2018 | M | 4,280 | $23.95 | A | 24,133 | D | |
| Common StockF2 | Aug 23, 2018 | S | 14,204 | $74.1079 | D | 9,929 | D | |
| Common StockF3 | Aug 23, 2018 | S | 620 | $74.9419 | D | 9,309 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $19.42 | Aug 23, 2018 | M | 10,544 | D | — | Feb 16, 2023 | Common Stock | 10,544 | 10,544 | D |
| Employee Stock Option (right to buy)F5 | $23.95 | Aug 23, 2018 | M | 4,280 | D | — | Nov 30, 2023 | Common Stock | 4,280 | 12,841 | D |
Explanation of responses
- F1Includes 497 shares acquired through the Employee Stock Purchase Plan for the phase ending in February 2018.
- F2Reflects the weighted average price of 14,204 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $73.80 to $74.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Reflects the weighted average price of 620 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $74.825 to $75.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The award vests in four equal installments on each of the first four anniversaries of the February 16, 2016 grant date.
- F5The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.